Karyopharm Therapeutics Inc. (KPTI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 1.1300 |
| Open | 1.1300 |
| Bid | 1.1400 x 1000 |
| Ask | 1.1700 x 1000 |
| Day's range | 1.1100 - 1.1850 |
| 52-week range | 0.6170 - 2.7900 |
| Volume | |
| Avg. volume | 1,419,105 |
| Market cap | 133.936M |
| Beta (5Y monthly) | 0.06 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Insider Sell: President and CEO Richard Paulson Sells 99,844 Shares of Karyopharm Therapeutics ...
President and CEO Richard Paulson executed a sale of 99,844 shares of Karyopharm Therapeutics Inc (NASDAQ:KPTI) on March 1, 2024, according to a recent SEC Filing.
- Insider Monkey
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcript
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q4 2023 Earnings Call Transcript February 29, 2024 Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS is $-0.36 EPS, expectations were $-0.29. FDS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name […]
- Thomson Reuters StreetEvents
Q4 2023 Karyopharm Therapeutics Inc Earnings Call
Q4 2023 Karyopharm Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.